ClinicalTrials.Veeva

Menu

The Impact of Misclassification of Obesity by Body Mass Index on Mortality in Patients With Chronic Kidney Disease

B

Buddhist Tzu Chi Medical Foundation

Status

Completed

Conditions

Chronic Kidney Diseases
Obesity

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT03285074
99-IRB-016-XD

Details and patient eligibility

About

Unlike the general population, a higher body mass index (BMI) is associated with greater survival among patients with chronic kidney disease (CKD). However, obesity is defined as excess body fat that associated with clearly elevated health risks according to the World Health Organization. In addition, muscle wasting is prevalent among CKD subjects. Thus, we hypothesized that different definition of obesity, based on BMI or body fat percentage, might have different impact on clinical outcomes among CKD population.

Enrollment

326 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects with non-dialysis CKD defined as estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m2

Exclusion criteria

  • subjects with liver cirrhosis
  • subjects with malignancy
  • subjects with an acute cardiovascular event within the 3 months before screening for inclusion
  • amputee
  • pregnancy
  • subjects with pacemaker
  • subjects with metallic implant

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems